Revvity Inc. stock (US76155R1086): NYSE price holds near 100 USD as technical levels draw focus

Revvity shares on the New York Stock Exchange are trading close to the 100 USD mark going into the new week, putting a key technical level in focus for investors in the United States and abroad.

Revvity shares on the New York Stock Exchange are trading close to the psychologically important 100 USD line as investors assess the healthcare tools group's positioning in the United States market and its recent trading pattern, according to ad-hoc-news coverage of the stock going into the weekend.

The stock, listed under the ticker RVTY on the NYSE, has been hovering around this round-number threshold, which many market participants use as a reference point when evaluating short-term technical signals and potential support and resistance levels in the US home market.

At the US home exchange, the stock price around the 100 USD mark reflects how investors currently value Revvity relative to other life science and diagnostics names that also trade in New York, even as broader healthcare indices in the United States continue to show differentiated performance across subsectors.

While intraday volatility and closing levels can shift from session to session, the focus on the 100 USD area on the NYSE underscores how round price levels often become reference points for chart-oriented market participants in the United States.

For investors following the stock from Germany, Revvity is also available via German trading venues such as Tradegate, where the share is quoted in euros and can track movements in the US home listing with typical currency and liquidity differences.

Viewed against its recent range, the price region around 100 USD positions the stock roughly in the middle of its broader trading corridor over the past year, rather than at an extreme high or low, which can shape how investors in the United States interpret momentum and risk.

Market data providers and valuation services that follow Revvity as RVTY on the NYSE indicate that the share price around this level is frequently used as an input when estimating multiples, discounting projected cash flows, and comparing the company to peers in the life sciences tools industry.

As of: 05/31/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Revvity Inc.
• Sector/industry: Life sciences tools and diagnostics
• Headquarters/country: Waltham, United States
• Core markets: North America, Europe, Asia-Pacific
• Key revenue drivers: Laboratory instruments, consumables, and diagnostic solutions for research and clinical customers
• Home exchange/listing venue: New York Stock Exchange (RVTY)
• Trading currency: USD

Revvity Inc.: core business model

Revvity operates as a diversified provider of laboratory technologies and diagnostic solutions, generating revenue primarily by supplying instruments, consumables, software and services to research, pharmaceutical and clinical customers worldwide.

Chart technicals and 52-week range

From a chart perspective, Revvity has traded within a 52-week corridor that frames the current level near 100 USD as a mid-range zone rather than at the extremes of its yearly high or low, which can temper interpretations of either strong upside momentum or pronounced downside pressure.

Technical observers often watch how the share behaves around such round-number levels and within its 52-week span, monitoring whether the price holds, rebounds or slips away from these areas in relation to moving averages and volume patterns when assessing the stock's short-term configuration.

Conclusion

The current trading zone around 100 USD on the New York Stock Exchange keeps Revvity in focus for investors who monitor round-number levels and mid-range positions within a 52-week corridor when assessing near-term developments.

Against this backdrop, the chart-based view outlined above provides an additional lens alongside fundamental considerations for how the market is currently calibrating expectations for the life sciences tools group.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.